Shikhar Mehrotra to Th17 Cells
This is a "connection" page, showing publications Shikhar Mehrotra has written about Th17 Cells.
Connection Strength
0.248
-
CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response. Cell Metab. 2018 01 09; 27(1):85-100.e8.
Score: 0.137
-
Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors. Cancer Res. 2014 Nov 01; 74(21):6048-59.
Score: 0.110